1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Biopharmaceutical CMO Market, By Product
5.1 Introduction
5.2 Biologics
5.2.1 Antisense, RNAi, & Molecular Therapy
5.2.2 Recombinant Proteins
5.2.3 Monoclonal antibodies (MAbs)
5.2.4 Vaccines
5.2.5 Other Biologics
5.3 Biosimilars
5.4 Other Products
6 Global Biopharmaceutical CMO Market, By Source
6.1 Introduction
6.2 Non-mammalian
6.3 Mammalian
6.4 Other Sources
7 Global Biopharmaceutical CMO Market, By Service
7.1 Introduction
7.2 Contract Manufacturing
7.2.1 Analytical & QC Studies
7.2.2 Fill & Finish Operations
7.2.3 Process Development
7.2.3.1 Downstream
7.2.3.2 Upstream
7.2.4 Packaging
7.3 Contract Research
7.3.1 Inflammation & Immunology
7.3.2 Neuroscience
7.3.3 Oncology
7.3.4 Cardiology
7.4 Other Services
8 Global Biopharmaceutical CMO Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 JRS Pharma
10.2 Toyobo Co., Ltd.
10.3 Rentschler Biopharma SE
10.4 Inno Biologics Sdn Bhd
10.5 Fujifilm Diosynth Biotechnologies U.S.A., Inc.
10.6 Laboratory Corporation of America Holdings
10.7 Biomeva GmbH
10.8 Samsung Biologics
10.9 ProBioGen AG
10.10 Boehringer Ingelheim GmbH
10.11 Lonza Group AG
10.12 CMC Biologics
10.13 ICON Plc
10.14 AbbVie Inc.
10.15 Thermo Fisher Scientific Inc (Patheon & PPD)
List of Tables
Table 1 Global Biopharmaceutical CMO Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Biopharmaceutical CMO Market Outlook, By Product (2021-2030) ($MN)
Table 3 Global Biopharmaceutical CMO Market Outlook, By Biologics (2021-2030) ($MN)
Table 4 Global Biopharmaceutical CMO Market Outlook, By Antisense, RNAi, & Molecular Therapy (2021-2030) ($MN)
Table 5 Global Biopharmaceutical CMO Market Outlook, By Recombinant Proteins (2021-2030) ($MN)
Table 6 Global Biopharmaceutical CMO Market Outlook, By Monoclonal antibodies (MAbs) (2021-2030) ($MN)
Table 7 Global Biopharmaceutical CMO Market Outlook, By Vaccines (2021-2030) ($MN)
Table 8 Global Biopharmaceutical CMO Market Outlook, By Other Biologics (2021-2030) ($MN)
Table 9 Global Biopharmaceutical CMO Market Outlook, By Biosimilars (2021-2030) ($MN)
Table 10 Global Biopharmaceutical CMO Market Outlook, By Other Products (2021-2030) ($MN)
Table 11 Global Biopharmaceutical CMO Market Outlook, By Source (2021-2030) ($MN)
Table 12 Global Biopharmaceutical CMO Market Outlook, By Non-mammalian (2021-2030) ($MN)
Table 13 Global Biopharmaceutical CMO Market Outlook, By Mammalian (2021-2030) ($MN)
Table 14 Global Biopharmaceutical CMO Market Outlook, By Other Sources (2021-2030) ($MN)
Table 15 Global Biopharmaceutical CMO Market Outlook, By Service (2021-2030) ($MN)
Table 16 Global Biopharmaceutical CMO Market Outlook, By Contract Manufacturing (2021-2030) ($MN)
Table 17 Global Biopharmaceutical CMO Market Outlook, By Analytical & QC Studies (2021-2030) ($MN)
Table 18 Global Biopharmaceutical CMO Market Outlook, By Fill & Finish Operations (2021-2030) ($MN)
Table 19 Global Biopharmaceutical CMO Market Outlook, By Process Development (2021-2030) ($MN)
Table 20 Global Biopharmaceutical CMO Market Outlook, By Downstream (2021-2030) ($MN)
Table 21 Global Biopharmaceutical CMO Market Outlook, By Upstream (2021-2030) ($MN)
Table 22 Global Biopharmaceutical CMO Market Outlook, By Packaging (2021-2030) ($MN)
Table 23 Global Biopharmaceutical CMO Market Outlook, By Contract Research (2021-2030) ($MN)
Table 24 Global Biopharmaceutical CMO Market Outlook, By Inflammation & Immunology (2021-2030) ($MN)
Table 25 Global Biopharmaceutical CMO Market Outlook, By Neuroscience (2021-2030) ($MN)
Table 26 Global Biopharmaceutical CMO Market Outlook, By Oncology (2021-2030) ($MN)
Table 27 Global Biopharmaceutical CMO Market Outlook, By Cardiology (2021-2030) ($MN)
Table 28 Global Biopharmaceutical CMO Market Outlook, By Other Services (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
